Innovations in Oncology is Focus of AMCP Foundation’s 9th Annual Research Symposium
The AMCP Foundation’s 9th Annual Research Symposium gathered some of the country’s top oncology leaders for a half-day discussion on many opportunities and challenges facing innovation in curative therapies and improvements to cancer care. The event was held Oct. 29 in conjunction with AMCP Nexus 2019.
A key theme running through the presentations was the increasing need for more effective data to improve decision-making and develop innovative patient care that enhances outcomes.
“Our central commitment is to facilitate innovative research about the evolving health care environment,” said AMCP Foundation Executive Director Paula J. Eichenbrenner, MBA, CAE. “It is especially timely that we convene around cancer care, with 1.73 million new diagnoses annually in this country, and a persistently high mortality rate, and nearly $150 billion in healthcare expenditures related to oncology.”
With a long history of commitment to advance research and informing health care professionals, the symposium exposed attendees to the viewpoints and insights of national experts on evolving technologies, new treatment decision paradigms, the use of big data and innovative ways to address affordability of cancer treatment. Presenters also addressed data use in clinical decision making, patient’s concerns about costs, health plan designs and use of data in shared decision-making; as well as use of health IT and artificial intelligence to advance research and accelerate regulatory approval.
A summary of the 11 presentations is scheduled to be available on the Foundation’s website in early December. Key highlights of the presentations will be featured in a follow-up webinar Jan. 16, and an executive summary of the symposium will be included in a future issue of the AMCP Journal of Managed Care and Specialty Pharmacy. Read the full symposium agenda and program, including speaker previews of their presentations.